Friday, November 28, 2025

AAA-Pharma and XO Life Launch Strategic Partnership for Digital Therapy Support for Patients with Chronic Conditions

AAA-Pharma, a long-standing player in the generics market, is launching a forward-looking partnership with XO Life, a leading health-tech company. The joint initiative aims to provide patients with a modern combination of proven medications and digital guidance. The collaboration enables a sustainable improvement in care quality and strengthens orientation throughout the therapy journey.

Enhanced support for people with chronic diseases

Chronic conditions such as hypertension, diabetes mellitus, respiratory diseases, and psychological or neurological challenges affect millions worldwide. If these conditions are not identified early or managed adequately, the risk of severe secondary complications increases significantly. Despite available treatment options, many patients remain uncertain about which measures are individually appropriate and how lifestyle adjustments can sustainably support long-term treatment success.

With its broad portfolio of high-quality prescription generics, AAA-Pharma aims not only to supply patients with reliable pharmaceuticals but also to provide day-to-day guidance. Through the new partnership with XO Life, this support is now expanded digitally: via the brite™ platform, patients can document their health metrics, track their progress, and receive personalized, evidence-based recommendations.

A digital platform fostering safety and self-management

The XO Life platform offers access to guideline-based information, tailored insights, and moderated peer-support communities. By combining established pharmaceutical quality with innovative digital tools, the partnership empowers patients to take a more active role in their therapy.

Felix Hollmann, Managing Director of AAA-Pharma, emphasizes: “Chronic conditions often come with uncertainties and information gaps. We want to provide patients not only with proven generics but also with digital support to strengthen their long-term health.”

Dr. Friderike Bruchmann, Co-Founder & CEO of XO Life, adds: “Our collaboration with AAA-Pharma enables digital support that helps people manage their condition in everyday life. With brite™, users gain access to clear, scientifically validated information and a protected exchange with others. This empowers patients to make confident decisions and take charge of their health.”

Easy registration and direct access

Registration is simple via the web portal or the iOS and Android apps. Users receive direct access to a range of therapy areas, including:

• Metabolism (e.g., diabetes)
• Respiratory health (e.g., COPD)